Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

@article{Donnelly2019RevisionAU,
  title={Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium},
  author={J Peter Donnelly and Sharon C-A Chen and Carol A. Kauffman and William J. Steinbach and John W Baddley and Paul E. Verweij and Cornelius J. Clancy and John R. Wingard and Shawn R. Lockhart and Andreas H. Groll and Tania C. Sorrell and Matteo Bassetti and Hamdi Akan and Barbara Dudley Alexander and David R. Andes and {\'E}lie Azoulay and Ralf Bialek and Robert W. Bradsher and St{\'e}phane Bretagne and Thierry Calandra and Angela M. Caliendo and Elio Castagnola and Mario Cruciani and Manuel Cuenca‐Estrella and Catherine F. Decker and Sujal R. Desai and Brian T. Fisher and Thomas S. Harrison and Claus Peter Heussel and Henrik Elvang Jensen and Christopher C. Kibbler and Dimitrios P. Kontoyiannis and B J Kullberg and Katrien Lagrou and Fr{\'e}d{\'e}ric Lamoth and Thomas Lehrnbecher and Jurgen Loeffler and Olivier Lortholary and Johan Maertens and Oscar Marchetti and Kieren A Marr and Henry Masur and Jacques F. Meis and C Orla Morrisey and Marcio Nucci and Luis Ostrosky-Zeichner and Livio Pagano and Thomas F. Patterson and John R. Perfect and Zdeněk R{\'a}{\vc}il and Emmanuel Roilides and M. Ruhnke and Cornelia Schaefer Prokop and Shmuel Shoham and Monica A. Slavin and David A. Stevens and George R. Thompson and Jose A. Vazquez and Claudio Viscoli and Thomas J. Walsh and Adilia Warris and L Joseph Wheat and P. Lewis White and Theoklis Zaoutis and Peter G. Pappas},
  journal={Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America},
  year={2019},
  volume={71},
  pages={1367 - 1376}
}
  • J. Donnelly, S. Chen, P. Pappas
  • Published 5 December 2019
  • Medicine
  • Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Abstract Background Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell… 

Tables from this paper

EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.

  • M. BassettiÉ. Azoulay T. Calandra
  • Biology, Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2021
TLDR
The aim of this article is to review progresses made in recent years and difficulties remaining in the development of definitions applicable in the ICU setting.

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021

TLDR
This article introduces the fourth update of the Australian and New Zealand consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting and introduces an entirely new chapter dedicated to helping healthcare workers convey important concepts related to IFD, infection prevention and antIFungal therapy, to patients.

Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?

TLDR
The updated IA consensus definitions may impact future trial designs, especially for antifungal prophylaxis studies.

Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021

TLDR
Novel antifungal agents still in clinical trial which offer substantial potential for improved outcomes in the future are outlined, which will continue to improve the poor outcomes that have been traditionally associated with IFD due to NAM.

Invasive and Subcutaneous Infections Caused by Filamentous Fungi: Report from a Portuguese Multicentric Surveillance Program

TLDR
A high diversity of species were involved in deep fungal infections, which has implications for clinical and laboratory diagnosis, and on the therapeutic management of these infections, since different species, even within the same genus, can present diverse patterns of susceptibility to antifungals.

Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis

TLDR
DCP is a feasible strategy in the management of IFD and limits unnecessary antimould treatment during intensive chemotherapy and the poor performance of serial serum galactomannan screening in detecting IA warrants further investigation.

Advances in the diagnosis of fungal pneumonias

ABSTRACT Introduction Fungal infections are increasingly encountered in clinical practice due to more favorable environmental conditions and increasing prevalence of immunocompromised individuals.

Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study

TLDR
This study highlights the shift in epidemiology and raises concern of high MICs to azoles among the authors' isolates and warrants regular surveillance, which can provide the local clinically correlated microbiological data to clinicians and which might aid in guiding patient treatment.
...

References

SHOWING 1-10 OF 86 REFERENCES

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

  • B. D. de PauwT. Walsh J. Bennett
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2008
TLDR
These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.

Epidemiology of Invasive Fungal Disease in Children

TLDR
This review focuses on fungal disease epidemiology with a specific emphasis on the 2 most common pediatric IFDs, IC and invasive aspergillosis (IA).

PCR in Diagnosis of Invasive Aspergillosis: a Meta-Analysis of Diagnostic Performance

TLDR
The pooled diagnostic performance of whole-blood and serum PCR assays was moderate, with a sensitivity and specificity of 84% and 76% suggesting that a positive or negative result is unable, on its own, to confirm or exclude a suspected infection.

β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

  • F. LamothM. Cruciani O. Marchetti
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
TLDR
Different BG assays have similar accuracy for the diagnosis of IFI in hemato-oncological patients, and the diagnostic performance of the BG assay in proven or probable IFI was better with 2 consecutive positive test results.

Aspergillus PCR: One Step Closer to Standardization

TLDR
Meta-regression analysis showed positive correlations between sensitivity and extraction protocols incorporating the proposed recommendations and the use of bead beating, white cell lysis buffer, and an internal control PCR in the European Aspergillus PCR Initiative.

Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children

TLDR
Fungal biomarker tests performed on blood, other body fluids, or tissue specimens represent promising adjuncts to the diagnostic armamentarium in populations with a high prevalence of invasive fungal disease, but substantial gaps exist in the correct use and interpretation of these diagnostic tools in pediatric patients.

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

  • D. KontoyiannisK. Marr P. Pappas
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
TLDR
In this national prospective surveillance study of IFIs in HSCT recipients, the cumulative incidence was highest for aspergillosis, followed by candidiasis, and understanding the epidemiologic trends and burden of IFI may lead to improved management strategies and study design.

Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases

TLDR
Immune reconstitution, rather than specific antifungal therapy, was found to be the best predictor of survival and common findings between adult and pediatric invasive aspergillosis were revealed.

Diagnostic Accuracy of Serum 1,3-β-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis

TLDR
The diagnostic accuracy of the BG assay is high for PJP and moderate for IFI, and the sensitivity for P JP is particularly high, so it can be used as a screening tool forPJP.

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

TLDR
BDG monitoring may be useful for identifying ICU patients at highest risk to develop an IFI as well as for monitoring treatment response, and preemptive strategies based on fungal biomarkers warrant further study.
...